Skip to main content
DVx Inc. logo

DVx Inc. — Investor Relations & Filings

Ticker · 3079 ISIN · JP3548710007 T Manufacturing
Open in API
Filings indexed 66 across all filing types
Latest filing 2026-05-22 Board/Management Inform…
Country JP Japan
Listing T 3079

About DVx Inc.

https://www.dvx.jp/

DVx Inc. is a company that provides sales and solutions for advanced medical devices, primarily focusing on the cardiovascular disease field. Its operations encompass the entire lifecycle of medical equipment, including research and development, design, manufacturing, import/export, purchasing, and sales. The company's product portfolio is centered on the treatment of arrhythmia and includes devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and ablation catheters. In addition to product distribution, DVx Inc. offers comprehensive support services, which include the repair, maintenance, inspection, and rental of medical devices.

Recent filings

Filing Released Lang Actions
代表取締役の異動（追加選定）および役員人事に関するお知らせ
Board/Management Information Classification · 95% confidence The document is an official announcement from DeepX Co., Ltd. detailing changes to the board of directors and senior management (new representative director appointments, director candidate lists, audit committee appointments, retirements). It does not contain financial statements or reporting data, nor is it a mere notice of report publication. It specifically addresses board/management personnel changes, matching the Board/Management Information category.
2026-05-22 Japanese
臨時報告書
M&A Activity Classification · 85% confidence The document is a Japanese “臨時報告書” (timely disclosure report) filed under the Financial Instruments and Exchange Act describing a share exchange agreement to effect a management integration and create a wholly owned subsidiary (a classic M&A transaction). It details the share exchange ratio, corporate contracts, and merger considerations. This is clearly an M&A announcement, fitting our “M&A Activity” definition.
2026-05-22 Japanese
オルバヘルスケアホールディングスとディーブイエックスとの株式交換契約の締結、並びに、親会社、主要株主及び主要株主である筆頭株主の異動等に関するお知らせ
M&A Activity Classification · 90% confidence The document is a formal announcement detailing the execution of a management integration contract and a share‐exchange agreement between two listed Japanese companies, including timetable, exchange ratios, approval conditions, and related corporate changes. This is clearly an M&A transaction announcement (share exchange to create a wholly‐owned subsidiary), fitting the “M&A Activity” category.
2026-05-22 Japanese
2026年３月期（累計）業績予想の修正に関するお知らせ
Regulatory Filings
2026-04-20 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-5-2, Paragraph 1. It serves as an officer certification by the CEO of DVx Inc. confirming the accuracy of the semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a report (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 40
2025-11-14 Japanese
半期報告書－第40期(2025/04/01－2025/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet and management analysis for the interim period ending September 30, 2025. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2026
2025-11-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.